Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...

TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough solution. Larry Ferguson, 77, of Pontotoc, is among those whose ...

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...

Inspire is dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea. Disclaimer: This is an AI-generated summary of a press ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...